- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Oxygenta Pharmaceutical Ltd manufactures Bulk Drugs and API including Pharmaceutical preparation, and Organic Fine Chemicals.Products: Losartan potassium intermediate, Gabapentin intermediate, Antihypertensive drugs, Anti cancer drugs, Antiulcer drugs, Antiretroviral drugs, Antihypertensive drugs, Antiviral drugs.
Oxygenta Pharmaceutical Limited, a subsidiary of VIRUPAKSHA ORGANICS LIMITED, has announced the publication of the notice for its 33rd Annual General Meeting (AGM) for the financial year 2025-26. This important notice for shareholders was published in both Financial Express (English) and Ninadam (Telugu) newspapers. Investors can also access these publications...